EUVIMEDEUVIMED entdecken
Crossref

Phantosmia during proton radiation and differences in frequency of phantosmia rates based on proton craniospinal irradiation technique for pediatric brain tumor patients

Myrsini Ioakeim-Ioannidou, Juliane Daartz, Parsa Erfani, Tobias Urell, Arthur Lalonde, Julia Berv, Shannon Leahy, Barbara Fullerton, Rachel Bolton, Torunn Yock iD, Nancy Tarbell, Beow Yeap und 1 weitere

Pediatric Blood & Cancer · 2024

DOI: 10.1002/pbc.30927 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2024. Verfasst von Myrsini Ioakeim-Ioannidou und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Craniospinal Irradiation, Brain Neoplasms, Proton Therapy, Olfaction Disorders. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 16 Literaturangaben. Gefördert von: Pediatric Cancer Registry, MIM corporation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Unusual olfactory perception, often referred to as “phantosmia” or “cacosmia” has been reported during brain radiotherapy (RT), but is infrequent and does not typically interfere with the ability to deliver treatment. We seek to determine the rate of phantosmia for patients treated with proton craniospinal irradiation (CSI) and identify any potential clinical or treatment‐related associations.

Methods

We performed a retrospective review of 127 pediatric patients treated with CSI, followed by a boost to the brain for primary brain tumors in a single institution between 2016 and 2021. Proton CSI was delivered with passive scattering (PS) proton technique ( n = 53) or pencil beam scanning technique (PBS) ( n = 74). Within the PBS group, treatment delivery to the CSI utilized a single posterior (PA) field ( n = 24) or two posterior oblique fields ( n = 50). We collected data on phantom smell, nausea/vomiting, and the use of medical intervention.

Results

Our cohort included 80 males and 47 females. The median age of patients was 10 years (range: 3–21). Seventy‐one patients (56%) received concurrent chemotherapy. During RT, 104 patients (82%) developed worsening nausea, while 63 patients (50%) reported episodes of emesis. Of those patients who were awake during CSI ( n = 59), 17 (29%) reported phantosmia. In the non‐sedated group, we found a higher rate of phantosmia in patients treated with PBS ( n = 16, 42%) than PS ( n = 1, 4.7%) ( p = .002). Seventy‐eight patients (61%) required medical intervention after developing nausea/vomiting or phantosmia during RT. Two patients required sedation due to the malodorous smell during CSI. We did not find any significant difference in nausea/vomiting based on treatment technique.

Conclusion

Proton technique significantly influenced olfactory perception with greater rates of phantosmia with PBS compared to PS. Prospective studies should be performed to determine the cause of these findings and determine techniques to minimize phantosmia during radiation therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Craniospinal IrradiationBrain NeoplasmsProton TherapyOlfaction DisordersMaleFemaleHumansChildChild, PreschoolAdolescentYoung AdultAdultProtonsProspective StudiesVomitingNauseaRadiotherapy Dosage

Stichwörter der Autor:innen

brain tumorspediatric cancerphantosmiaprotonsradiation modalitiestreatment effect

Substanzen

Protons

Autor:innen und Institutionen

  • Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Internal Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Centre Hospitalier de l'Universite de Montreal, Montreal, Quebec, Canada.
  • Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Department of Internal Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.

ORCID-Profile: Torunn Yock, Shannon M MacDonald

Förderung

  • Pediatric Cancer Registry
  • MIM corporation

Zitieren

APA

Ioakeim-Ioannidou, M., Daartz, J., Erfani, P., Urell, T., Lalonde, A., Berv, J., Leahy, S., Fullerton, B., Bolton, R., Yock, T., Tarbell, N., Yeap, B., & MacDonald, S. M. (2024). Phantosmia during proton radiation and differences in frequency of phantosmia rates based on proton craniospinal irradiation technique for pediatric brain tumor patients. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.30927

Vancouver

Ioakeim-Ioannidou M, Daartz J, Erfani P, Urell T, Lalonde A, Berv J, et al. Phantosmia during proton radiation and differences in frequency of phantosmia rates based on proton craniospinal irradiation technique for pediatric brain tumor patients. Pediatric Blood & Cancer. 2024. doi:10.1002/pbc.30927

BibTeX
@article{IoakeimIoannidou2024,
  author = {Ioakeim-Ioannidou, Myrsini and Daartz, Juliane and Erfani, Parsa and Urell, Tobias and Lalonde, Arthur and Berv, Julia and Leahy, Shannon and Fullerton, Barbara and Bolton, Rachel and Yock, Torunn and Tarbell, Nancy and Yeap, Beow and MacDonald, Shannon M},
  title = {Phantosmia during proton radiation and differences in frequency of phantosmia rates based on proton craniospinal irradiation technique for pediatric brain tumor patients},
  journal = {Pediatric Blood & Cancer},
  year = {2024},
  doi = {10.1002/pbc.30927}
}
Kostenlos starten →